```html

Zygotic Discordance (Twin Mismatch)

What is Zygotic Discordance (Twin Mismatch)?

Zygotic discordance, often referred to as “twin mismatch,” describes a situation in which twins develop from two separate fertilized eggs (dizygotic twins) but exhibit significant differences in growth, size, or health status while in utero. Unlike identical (monozygotic) twins that share the same genetic material, dizygotic twins are genetically distinct—much like regular siblings. Discordance becomes clinically relevant when one twin’s development diverges markedly from the other’s, leading to potential complications for one or both fetuses.

In obstetric practice, the term is used mainly to flag abnormal findings on ultrasound or prenatal testing that suggest a “mismatch” in placental function, amniotic fluid volume, or fetal well‑being. Recognizing zygotic discordance early allows clinicians to monitor the pregnancy more closely and intervene when necessary.

Sources: Mayo Clinic; American College of Obstetricians and Gynecologists (ACOG); National Institute of Child Health and Human Development (NICHD).

Common Causes

While the exact cause of discordant growth is often multifactorial, several maternal, fetal, and placental conditions are known to increase the risk.

• Placental insufficiency – One placenta may receive less blood flow, limiting nutrients and oxygen.
• Unequal sharing of the placenta – In dichorionic‑diamniotic twins each placenta is separate, but differences in size or vascular connections can create a mismatch.
• Maternal hypertension or pre‑eclampsia – High blood pressure can impair uteroplacental circulation.
• Maternal diabetes (pre‑gestational or gestational) – Can cause one twin to become macrosomic while the other remains small.
• Infection – Cytomegalovirus, rubella, or other intrauterine infections may affect one twin more severely.
• Chromosomal or genetic abnormalities – One twin may have trisomy 21, Turner syndrome, etc., altering growth patterns.
• Twin‑to‑twin transfusion syndrome (TTTS) – A rare complication of monochorionic twins where blood flows unevenly between twins.
• Umbilical cord problems – Knotting, nuchal cords, or a short cord can restrict blood flow to one twin.
• Maternal substance use – Smoking, alcohol, or illicit drugs can impair placental function selectively.
• Maternal malnutrition or low BMI – May not support optimal growth for both fetuses.

Associated Symptoms

Because the condition occurs inside the womb, pregnant individuals may not feel any direct symptoms. However, the following signs can suggest that a discordance is developing:

• Sudden change in fetal movement patterns (one twin moves less or more than usual).
• Unexplained abdominal pain or pelvic pressure.
• Vaginal bleeding or spotting.
• New‑onset swelling (edema) or rapid weight gain, especially if linked to hypertension.
• Signs of maternal infection (fever, chills, urinary symptoms).

If any of these symptoms appear, prompt obstetric evaluation is warranted.

When to See a Doctor

The following situations should trigger an immediate call to your obstetric provider or a visit to urgent care:

• Noticeable decrease in fetal movement for one twin.
• Severe or persistent abdominal pain, especially if it radiates to the back.
• Heavy vaginal bleeding (soaking a pad in < 5 minutes) or bright red clots.
• Sudden onset of high blood pressure (≥140/90 mmHg) or severe headache/visual changes.
• Signs of pre‑term labor (regular contractions, cervical change).
• Any new symptom that feels “different” from previous pregnancies.

Early contact with your care team can prevent complications such as intrauterine growth restriction (IUGR), preterm birth, or stillbirth.

Diagnosis

Diagnosing zygotic discordance involves a combination of imaging, maternal health assessment, and sometimes invasive testing.

1. Ultrasound

• Bi‑weekly or weekly growth scans after 20 weeks to measure each twin’s biometric parameters (head circumference, abdominal circumference, femur length).
• Doppler studies of the umbilical artery and middle cerebral artery to assess blood flow.
• Evaluation of amniotic fluid volume (AFI) for each sac.

2. Maternal Blood Tests

• Complete blood count, glucose tolerance test, and thyroid panel to rule out systemic contributors.
• Serologic testing for infections (CMV, toxoplasmosis, rubella).

3. Cervical Length Measurement

Shortening < 2.5 cm before 24 weeks can indicate higher risk for preterm delivery, especially in discordant twins.

4. Invasive Testing (When Indicated)

• Amniocentesis for karyotyping or genetic microarray if a chromosomal abnormality is suspected.
• Chorionic villus sampling (CVS) earlier in pregnancy for genetic analysis.

5. Fetal Monitoring

Non‑stress tests (NST) and biophysical profiles (BPP) are performed after 28 weeks or earlier if growth lag is noted.

Treatment Options

Management is individualized based on gestational age, severity of discordance, and underlying cause.

1. Close Surveillance

• Frequent ultrasounds (every 1–2 weeks) to track growth trajectories.
• Serial Doppler studies to monitor placental blood flow.

2. Maternal Health Optimization

• Control blood pressure with pregnancy‑safe antihypertensives (e.g., labetalol, nifedipine).
• Maintain optimal glycemic control if diabetic (diet, insulin, or oral agents as advised).
• Nutrition counseling—high‑protein, adequate calories, prenatal vitamins with DHA.
• Smoking cessation programs and avoidance of alcohol/drugs.

3. Targeted Interventions

• Selective fetoscopic laser therapy for TTTS (monochorionic twins only).
• Amnioreduction to balance amniotic fluid volumes in cases of severe polyhydramnios affecting one twin.
• Corticosteroids (betamethasone or dexamethasone) between 24‑34 weeks to accelerate fetal lung maturity if early delivery is anticipated.
• Tocolytics (e.g., nifedipine) to delay preterm labor while interventions are arranged.

4. Delivery Planning

• If one twin shows severe growth restriction (estimated fetal weight < 3rd percentile) or abnormal Doppler studies, delivery may be recommended as early as 34‑36 weeks.
• Mode of delivery (vaginal vs. cesarean) is decided based on fetal presentation, estimated weights, and obstetric history.

5. Post‑natal Care

• Neonatal intensive care unit (NICU) support for the smaller or compromised twin.
• Early developmental assessments and follow‑up for any genetic or metabolic issues.

Prevention Tips

While you cannot change the fact that you are carrying twins, certain steps can reduce the risk of severe discordance:

• Pre‑conception health check – Optimize weight, manage chronic conditions (hypertension, diabetes), and update vaccinations.
• Early prenatal care – First‑trimester ultrasound to confirm chorionicity and baseline growth.
• Balanced nutrition – Aim for 300–350 extra calories per day, adequate protein (≥ 71 g), iron, calcium, and omega‑3 fatty acids.
• Avoid tobacco, alcohol, and illicit drugs – All are linked to placental dysfunction.
• Control blood pressure early – Lifestyle modifications and medication when indicated.
• Regular prenatal visits – Enables early detection of blood‑pressure spikes, gestational diabetes, or infection.
• Manage stress – Chronic stress may affect uterine blood flow; consider mindfulness, yoga, or counseling.

Emergency Warning Signs

Key Take‑aways

• Zygotic discordance refers to unequal growth or health status between dizygotic twins.
• Common causes include placental insufficiency, maternal hypertension/diabetes, infections, and genetic abnormalities.
• Most women feel no direct symptoms; diagnosis relies on targeted ultrasound and maternal health assessment.
• Close monitoring, maternal condition optimization, and timely delivery are the cornerstones of management.
• Early prenatal care, a healthy lifestyle, and control of chronic conditions can lower the risk of severe discordance.

For personalized advice and a care plan tailored to your pregnancy, always discuss concerns with your obstetrician or a maternal‑fetal medicine specialist.

References:

• American College of Obstetricians and Gynecologists. “Twin Pregnancy.” ACOG Practice Bulletin, 2022.
• Mayo Clinic. “Intrauterine Growth Restriction (IUGR).” Updated 2023.
• National Institute of Child Health and Human Development. “Twin To Twin Transfusion Syndrome.” 2021.
• World Health Organization. “Recommendations on Antenatal Care for a Positive Pregnancy Experience.” 2022.
• Cleveland Clinic. “Management of High‑Risk Twin Pregnancies.” 2023.

```